日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pregnancy-Associated Spontaneous Coronary Dissection in a 32-Year-Old During the Third Trimester

一名32岁女性在妊娠晚期发生妊娠相关性自发性冠状动脉夹层

Tsianakas, Nikolaos; Oehmke, Frank; Müller, Vera; Lorenz, Jakob; Nef, Holger; Hamm, Christian; Sossalla, Samuel; Sander, Michael; Meinhold-Heerlein, Ivo; Dörr, Oliver

Microsatellite Markers in Biobanking: A New Multiplexed Assay

生物样本库中的微卫星标记:一种新的多重检测方法

Gretchen Smith, Debra Mathews, Samuel Sander-Effron, Deborah Requesens, Nahid Turan, Laura Scheinfeldt

CDK7 Inhibition Suppresses Castration-Resistant Prostate Cancer through MED1 Inactivation

CDK7抑制剂通过MED1失活抑制去势抵抗性前列腺癌

Reyaz Ur Rasool ,Ramakrishnan Natesan ,Qu Deng ,Shweta Aras ,Priti Lal ,Samuel Sander Effron ,Erick Mitchell-Velasquez ,Jessica M Posimo ,Shannon Carskadon ,Sylvan C Baca ,Mark M Pomerantz ,Javed Siddiqui ,Lauren E Schwartz ,Daniel J Lee ,Nallasivam Palanisamy ,Goutham Narla ,Robert B Den ,Matthew L Freedman ,Donita C Brady ,Irfan A Asangani

PARP-1 Expression Quantified by [18F]FluorThanatrace: A Biomarker of Response to PARP Inhibition Adjuvant to Radiation Therapy

通过 [18F]FluorThanatrace 定量 PARP-1 表达:放射治疗辅助 PARP 抑制反应的生物标志物

Samuel Sander Effron, Mehran Makvandi, Lilie Lin, Kuiying Xu, Shihong Li, Hsiaoju Lee, Catherine Hou, Daniel A Pryma, Cameron Koch, Robert H Mach

A Radiotracer Strategy to Quantify PARP-1 Expression In Vivo Provides a Biomarker That Can Enable Patient Selection for PARP Inhibitor Therapy

利用放射性示踪剂策略定量体内PARP-1表达,可提供一种生物标志物,用于筛选适合PARP抑制剂治疗的患者。

Makvandi, Mehran; Xu, Kuiying; Lieberman, Brian P; Anderson, Redmond-Craig; Effron, Samuel Sander; Winters, Harrison D; Zeng, Chenbo; McDonald, Elizabeth S; Pryma, Daniel A; Greenberg, Roger A; Mach, Robert H